Skip to Content

93 7455 (Glipizide and Metformin Hydrochloride 2.5 mg / 250 mg)

Pill with imprint 93 7455 is Pink, Elliptical / Oval and has been identified as Glipizide and Metformin Hydrochloride 2.5 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7455

Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Front
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455 Back
Glipizide and metformin hydrochloride 2.5 mg / 250 mg 93 7455

Glipizide and Metformin Hydrochloride

Imprint
93 7455
Strength
2.5 mg / 250 mg
Color
Pink
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7455
Inactive Ingredients
corn starch, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, polyethylene glycol 4000, polyvinyl alcohol, povidone k30, povidone k90, magnesium silicate, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.